Asad Haider

Stock Analyst at Goldman Sachs

(3.57)
# 2495
Out of 5,446 analysts
7
Total ratings
Success rate
Average return
7 Stocks
Name Action PT Current % Upside Ratings Updated
NAMS NewAmsterdam Pharma ...
Initiates Coverage On: Neutral
27
24.32 11.02% 1 Jul 17, 2025
BNTX BioNTech
Initiates Coverage On: Neutral
110
111.22 -1.1% 1 May 29, 2025
JNJ Johnson & Johnson
Upgrades: Buy
157 172
178.62 -3.71% 1 Apr 9, 2025
LLY Eli Lilly
Upgrades: Buy
892 888
704.92 25.97% 1 Apr 8, 2025
ABBV AbbVie
Assumes: Neutral
194
208.82 -7.1% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 25
25.41 -1.61% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
67 55
48.28 13.92% 1 Apr 8, 2025